Opportunities and pitfalls of cancer imaging in clinical trials

Diffusion-Weighted Magnetic Resonance Imaging as a Cancer Biomarker: Consensus and Recommendations

(2015) Anwar R. Padhani et al.   NEOPLASIA

Quantitative Imaging for Evaluation of Response to Cancer Therapy

(2014) Laurence P. Clarke et al.   Translational Oncology

Diffusion-weighted magnetic resonance imaging for pretreatment prediction and monitoring of treatment response of patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy

(2010) Line Nilsen et al.   ACTA ONCOLOGICA

Reproducibility of Perfusion Parameters in Dynamic Contrast-Enhanced MRI of Lung and Liver Tumors: Effect on Estimates of Patient Sample Size in Clinical Trials and on Individual Patient Responses

(2010) Chaan S. Ng et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents

(2010) J. E. Dancey et al.   CLINICAL CANCER RESEARCH

Biodistribution of 89Zr-trastuzumab and PET Imaging of HER2-Positive Lesions in Patients With Metastatic Breast Cancer

(2010) E C Dijkers et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Non FDG PET

(2010) C. Nanni et al.   CLINICAL RADIOLOGY

The biology underlying molecular imaging in oncology: from genome to anatome and back again

(2010) R.J. Gillies et al.   CLINICAL RADIOLOGY

A Comparative Study of Perfusion Measurement in Brain Tumours at 3 Tesla MR: Arterial Spin Labeling versus Dynamic Susceptibility Contrast-Enhanced MRI

(2010) P. Lehmann et al.   EUROPEAN NEUROLOGY

Use of new imaging techniques to predict tumour response to therapy

(2010) Vanessa N Harry et al.   LANCET ONCOLOGY

Targeting nanoparticles to cancer

(2010) M. Wang et al.   PHARMACOLOGICAL RESEARCH

Dynamic contrast-enhanced ultrasonography (DCE-US): a new tool for the early evaluation of antiangiogenic treatment

(2010) Nathalie Lassau et al.   Targeted Oncology

Whole body imaging in the abdominal cancer patient: pitfalls of PET-CT

(2009) Shaunagh McDermott et al.   ABDOMINAL IMAGING

Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer

(2009) P. Bystrom et al.   ANNALS OF ONCOLOGY

Regional chemotherapy for unresectable primary liver cancer: results of a phase II clinical trial and assessment of DCE-MRI as a biomarker of survival

(2009) W. R. Jarnagin et al.   ANNALS OF ONCOLOGY

A phase I study of the nitroimidazole hypoxia marker SR4554 using 19F magnetic resonance spectroscopy

(2009) C P Lee et al.   BRITISH JOURNAL OF CANCER

Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria

(2009) J. D. Wolchok et al.   CLINICAL CANCER RESEARCH

Clinical relevance of contrast-enhanced ultrasound in monitoring anti-angiogenic therapy of cancer: Current status and perspectives

(2009) Michele Lamuraglia et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Preliminary Study of Oxygen-Enhanced Longitudinal Relaxation in MRI: A Potential Novel Biomarker of Oxygenation Changes in Solid Tumors

(2009) James P.B. O'Connor et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Phase 0 Clinical Trials: An Answer to Drug Development Stagnation?

(2009) Patricia M. LoRusso   JOURNAL OF CLINICAL ONCOLOGY

Phase I and Biomarker Study of ABT-869, a Multiple Receptor Tyrosine Kinase Inhibitor, in Patients With Refractory Solid Malignancies

(2009) Chiung-Ing Wong et al.   JOURNAL OF CLINICAL ONCOLOGY

The Case Against Heavy PETing

(2009) Bruce Cheson   JOURNAL OF CLINICAL ONCOLOGY

Phase I Study of Intravenous Vascular Endothelial Growth Factor Trap, Aflibercept, in Patients With Advanced Solid Tumors

(2009) A. Craig Lockhart et al.   JOURNAL OF CLINICAL ONCOLOGY

Effect of adding temozolomide to radiation therapy on the incidence of pseudo-progression

(2009) Elizabeth R. Gerstner et al.   JOURNAL OF NEURO-ONCOLOGY

From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

(2009) R. L. Wahl et al.   JOURNAL OF NUCLEAR MEDICINE

Change in maximum standardized uptake value on repeat positron emission tomography after chemoradiotherapy in patients with esophageal cancer identifies complete responders

(2009) Robert J. Cerfolio et al.   JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY

Quantification of Tumor Microvascularity with Respiratory Gated Contrast Enhanced Ultrasound for Monitoring Therapy

(2009) Michalakis Averkiou et al.   ULTRASOUND IN MEDICINE AND BIOLOGY

Dynamic Contrast-enhanced CT of Head and Neck Tumors

(2008) Sotirios Bisdas et al.   ACADEMIC RADIOLOGY

MR Elastography of Liver Tumors: Preliminary Results

(2008) Sudhakar K. Venkatesh et al.   AMERICAN JOURNAL OF ROENTGENOLOGY

Imaging techniques to evaluate the response to treatment in oncology: Current standards and perspectives

(2008) C.D. Marcus et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Recommendations for the assessment of progression in randomised cancer treatment trials

(2008) J.E. Dancey et al.   EUROPEAN JOURNAL OF CANCER

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

(2008) E.A. Eisenhauer et al.   EUROPEAN JOURNAL OF CANCER

Brain tumor perfusion: Comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and contrast, pulsed arterial spin labeling, and H215O positron emission tomography

(2008) Lutz Lüdemann et al.   EUROPEAN JOURNAL OF RADIOLOGY

Evaluation of the role of magnetization transfer imaging in prostate: a preliminary study

(2008) Virendra Kumar et al.   MAGNETIC RESONANCE IMAGING

Colorectal Tumor Vascularity: Quantitative Assessment with Multidetector CT—Do Tumor Perfusion Measurements Reflect Angiogenesis?

(2008) Vicky Goh et al.   RADIOLOGY

Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy

(2007) M.A. Pantaleo et al.   CANCER TREATMENT REVIEWS